Estimating the Induction Period of Pleural Mesothelioma From Aggregate Data on Asbestos Consumption

Journal of Occupational and Environmental Medicine

Volumn 45, Issue 10, 2003, Pages 1107-1115

  Nurminen, Markku ^a   Karjalainen, Antti ^a   Takahashi, Ken ^b  

^a FINNISH INSTITUTE OF OCCUPATIONAL HEALTH   (Finland)

^b UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ASBESTOS;

ARTICLE; CANCER CLASSIFICATION; CANCER INCIDENCE; CANCER MORTALITY; CARCINOGENESIS; DATA BASE; DENMARK; ECOLOGY; FINLAND; FRANCE; GERMANY; HUMAN; JAPAN; NEW ZEALAND; PLEURA MESOTHELIOMA; POISSON DISTRIBUTION; STATISTICAL MODEL; SWEDEN; UNITED KINGDOM; WORLD HEALTH ORGANIZATION;

ASBESTOS; EUROPE; HUMANS; INCIDENCE; MALE; MESOTHELIOMA; OCCUPATIONAL DISEASES; OCCUPATIONAL EXPOSURE; PLEURAL NEOPLASMS; POISSON DISTRIBUTION; RISK; TIME FACTORS; WORLD HEALTH ORGANIZATION;

EID: 0242289650     PISSN: 10762752     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.jom.0000091682.95314.01     Document Type: Article

References (54)

1. Rothman KJ. Induction and latent periods. Am J Epidemiol. 1981;114:253-259.
2. Last JM, ed. A Dictionary of Epidemiology, 4th ed. Oxford: Oxford University Press; 2000.
3. Leigh J, Davidson P, Hendrie Berry D. Malignant mesothelioma in Australia, 1945-2000. Am J Ind Med. 2002;41: 188-201.
4. Leigh J. Presentation at the Fifth Meeting of the International Mesothelioma Interest Group. IMIG Newsletter Number 5, April 2001. Available at: http://www.imig.org/ (accessed May 30, 2002).
5. Rogers A. Asbestos exposure in various Australian industries-predictions of future disease incidence from Wittenoom. In: National Occupational Health and Safety Commission Research Report 1991-92. Canberra, Australia: Australian Government Publishing Service; 1991: 54-56.
6. Peto J, Decarli A, La Vecchia C, et al. The European mesothelioma epidemic. Br J Cancer. 1999;79:666-672.
7. Bianchi C, Brollo A, Ramani L, et al. World mesothelioma epidemic approaching fast. Ind Health. 2001;39:161-167.
8. Peto J, Hodgson JT, Mathews FE, et al. Continuing increase in mesothelioma mortality in Britain. Lancet. 1995;345: 535-539.
9. Price B. Analyses of current trends in US mesothelioma incidence. Am J Epidemiol. 1997;145:211-218.
10. Greenberg AK, Lee TC, Ross WN. The North American experience with mesothelioma incidence. In: Robinson BWS, Chahinian AP, eds. Mesothelioma. London: Martin Dunitz Ltd; 2002:1-27.
11. Ilg AG, Bignon J, Valleron AJ. Estimation of the past and future burden of mortality from mesothelioma in France. Occup Environ Med. 1998;55:760-765.
12. Rogers A. Predicting the future incidence of occupationally-related mesotheliomas. In: National Occupational Health and Safety Commission Research Report 1985-90. Canberra, Australia: Australian Government Publishing Service; 1991: 60-61.
13. Nakano T. Mesothelioma in Japan. In: Robinson BWS, Chahinian AP, eds. Mesothelioma. London: Martin Dunitz Ltd; 2002:351-358.
14. Rogers A. Predictions of mesothelioma in former Wittenoom asbestos workers [Letter]. Br J Ind Med. 1992;49:451-452.
15. Bianchi C, Giarelli L, Grandi G, et al. Latency periods in asbestos-related mesothelioma of the pleura. Eur J Cancer Prev. 1997;6:162-166.
16. Neumann V, Günther S, Müller KM, et al. Malignant mesothelioma - German mesothelioma register 1987-1999. Int Arch Occup Environ Health. 2001;74: 383-395.
17. Peto J, Seidman H, Selikoff IJ. Mesothelioma mortality in asbestos workers: implications for models of carcinogenesis and risk assessment. Br J Cancer. 1982; 45:124-135.
18. Boffetta P. Health effects of asbestos exposure in humans: a quantitative assessment. La Medicina del Lavoro. 1998; 89:471-480.
19. Albin M, Magnani C, Krstev S, et al. Asbestos and cancer: an overview of current trends in Europe. Environ Health Perspect. 1999;107:289.
20. Berry G. Prediction of mesothelioma, lung cancer, and asbestosis in former Wittenoom asbestos workers. Br J Ind Med. 1991;48:793-802.
21. Miettinen OS. Etiologic research. Needed revisions of concepts and principles. Scand J Work Environ Health. 1999;25: 484-490.
22. Langholtz B, Thomas D, Xiang A, et al. Latency analysis in epidemiologic studies of occupational exposures: application to the Colorado plateau uranium miners cohort. Am J Ind Med. 1999;35: 246-256.
23. Banaei A, Auvert B, Goldberg M, et al. Future trends in mortality of French men from mesothelioma. Occup Environ Med. 2000;57:488-494.
24. Hirvonen A, Mattson K, Karjalainen A, et al. SV40-like sequences are not necessary for the development of asbestos-induced mesothelioma. Mol Carcinog. 1999;26:93-99.
25. Kjaergaard J, Andersson M. Incidence rates of malignant mesothelioma in Denmark and predicted future number of cases among men. Scand J Work Environ Health. 2000;26:112-117.
26. Gaffuri E, Maranelli G. Prospettive di comparsa del mesotelioma pleurico in Italia. Med Lav. 1991;82:155-159.
27. Woitowitz HJ, Kraus T. Screening of asbestos-exposed workers in Germany. In: Tossavainen A, Lehtinen S, Huuskonen M, et al., eds. New Advances in Radiology and Screening of Asbestos-Related Diseases. Helsinki: People and Work 36, Finnish Institute of Occupational Health; 2000.
28. Järvholm B, Englund E, Albin M. Pleural mesothelioma in Sweden: an analysis of the incidence according to the use of asbestos. Occup Environ Med. 1999;56: 110-113.
29. Kjellström T, Smartt P. Increased mesothelioma incidence in New Zealand: the asbestos-cancer epidemic has started. N Z Med J. 2000;113:485-490.
30. Japan Customs, Ministry of Finance Japan. Trade Statistics. 2002. Available at: http://www.customs.go.jp/toukei/info/index_e.htm. (accessed March 27, 2002).
31. Available at: http://www.who.int/whosis/
32. Kjaergaard J, Andersson M. Incidence rates of malignant mesothelioma in Denmark and predicted future number of cases among men. Scand J Work Environ Health. 2000;26:112-117.
33. Available at: http://www.cancerregistry.fi/eng/statistics.htm. (accessed March 27, 2002).
34. Venables WN, Ripley BD. Modern Applied Statistics With S-PLUS, 3rd ed. New York: Springer; 2001.
35. Finnish Institute of Occupational Health (FIOH). Asbestos, asbestosis, and cancer: the Helsinki criteria for diagnosis and attribution. Scand J Work Environ Health. 1997;23:311-316.
36. Liang KY, Zeger SL. Longitudinal data analysis using generalised linear models. Biometrika. 1986;73:13-22.
37. Diggle PJ, Liang K-Y, Zeger SL. Analysis of Longitudinal Data. Oxford: Clarendon Press; 1994.
38. SAS Institute, Inc., SAS® Procedures Guide, Version 8. Cary, NC: SAS Institute Inc; 1999;1643 pp.
39. Greenland S. Introduction to regression modeling. In: Rothman KJ, Greenland S, eds. Modern Epidemiology, 2nd ed. Philadelphia: Lippincott-Raven Publishers; 1998.
40. Becker RA, Cleveland WS, Shya M-J, et al. A Tour of Trellis Graphics. Murray Hill, NJ: AT&T Bell Laboratories, Seattle, WA: Statistical Science Division, MathSoft; 1995.
41. Statistical Sciences, S-Plus for Windows User's Manual, version 3.1. Seattle: Statistical Sciences, Inc; 1993.
42. Rothman KJ, Greenland S. Causation and causal inference. In: Rothman KJ, Greenland S, eds. Modern Epidemiology, 2nd ed. Philadelphia, PA: Lippincott-Raven Publishers, 1998, p. 15.
43. Hemminki K, Xinjun L. Mesothelioma incidence seems to have levelled off in Sweden. Int J Cancer. 2002;103:145-146.
44. Björkqvist A-M, Tammilehto L, Nordling S, et al. Comparison of DNA copy number changes in malignant mesothelioma, adenocarcinoma and large cell anaplastic carcinoma of the lung. Br J Cancer. 1998;77:260-269.
45. Henderson DW, Shilkin KB, Whitaker D. Early diagnosis of asbestos-related cancers. In: Finnish Institute of Occupational health (FIOH). Asbestos, Asbestosis, and Cancer. Proceedings of an International Expert Meeting. Helsinki: FIOH; 1997. People and Work Research Report 14, 80-84.
46. Robins J, Greenland S. The probability of causation under a stochastic model for individual risk. Biometrics. 1989;45: 1125-1138.
47. Andersson M, Olsen JH. Trend and distribution of mesothelioma in Denmark. Br J Cancer. 1985;51:699-705.
48. Xu Z, Armstrong BK, Blundson BJ, et al. Trends in mortality from malignant mesothelioma of the pleura, and the production and use of asbestos in Australia. Med J Aust. 1985;143:185-187.
49. Takahashi K, Huuskonen MS, Tossavainen A, et al. Ecological relationship between mesothelioma incidence/mortality and asbestos consumption in the Western countries and Japan. J Occup Health. 1999;51:8-11.
50. Nurminen M. The epidemiologic relationship between pleural mesothelioma and asbestos exposure. Scand J Work Environ Health. 1975;1:128-137.
51. Nurminen M. The ecologic method: linkage failures and bias corrections. In: Corvalán C, Nurminen M, Pastides H, eds. Linkage Methods for Environment and Health Analysis. Technical Guidelines. Geneva: WHO; 1997:21-72.
52. Breslow NE, Day NE. Statistical Methods in Cancer Research. Volume II - The Design and Analysis of Cohort Studies. Lyon: World Health Organization, International Agency for Research on Cancer; 1987.
53. Hillerdal G. Mesothelioma: cases associated with non-occupational and low dose exposures. Occup Environ Med. 1999;56: 505-513.
54. Tossavainen A. Asbestos, asbestosis, and cancer: the Helsinki criteria for diagnosis and attribution. Scand J Work Environ Health. 2000;23:211-216.